Blood Tests for Empty Sella Syndrome
All patients with incidentally discovered empty sella should undergo comprehensive pituitary hormone testing at initial presentation, regardless of symptoms, as the presence or absence of symptoms does not reliably correlate with pituitary dysfunction. 1
Recommended Initial Blood Tests
Based on the 2025 Pituitary Society International Consensus Guidelines, the following baseline screening tests should be ordered 1:
Core Hormone Panel:
- Free thyroxine (T4) and thyroid-stimulating hormone (TSH)
- Morning cortisol (8 AM) and ACTH
- Luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
- Insulin-like growth factor 1 (IGF-1)
- Prolactin
Sex-Specific Hormones:
- Testosterone in men
- Estradiol in women (not needed in premenopausal women with regular menses)
Dynamic Testing Considerations
If morning cortisol levels suggest hypocortisolism, proceed with dynamic testing of the hypothalamus-pituitary-adrenal axis 1. Dynamic testing for growth hormone deficiency may be required in select patients after correction of other pituitary hormone deficiencies.
Clinical Context and Rationale
The guideline evidence is particularly strong here: among 402 patients with primary empty sella, 40.5% exhibited one or more axis deficiencies, with 29% of incidentally diagnosed patients showing hormonal abnormalities 1. The most common deficiencies in incidentally discovered empty sella include:
- Hypothyroidism (29.2% in symptomatic vs 2.8% in incidental)
- Growth hormone deficiency (20.4% vs 12.5%)
- Hypogonadism (50.4% vs 8.5%)
- Hyperprolactinemia (15.7% vs 2.9%)
- Hypocortisolism (17.7% vs 13.5%) 1
Important caveat: Patients with total empty sella are more likely to have hypopituitarism than those with partial empty sella, and progression from partial to total empty sella may be associated with hormonal deterioration 1.
Follow-Up Testing
Repeat pituitary hormone evaluation should be performed at 1-2 years or earlier if new clinical symptoms develop, as new hypopituitarism can develop without evidence of lesion growth 1. Male sex, clinical suspicion of pituitary disease, and traumatic brain injury predict higher risk of hypopituitarism 1.
The comprehensive testing approach is justified because symptoms are unreliable predictors of hormonal dysfunction—even asymptomatic patients frequently harbor significant endocrine abnormalities that impact morbidity and quality of life if left untreated 1, 2, 3.